Comparison of endoscopic resection, laparoscopic resection, and laparoscopic endoscopic cooperative surgery in esophageal or gastric subepithelial lesions in a Thai medical school
Artikel-Kategorie: Original article
Online veröffentlicht: 08. Sept. 2025
Seitenbereich: 209 - 217
DOI: https://doi.org/10.2478/abm-2025-0026
Schlüsselwörter
© 2025 Phuphat Vongwattanakit et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Esophageal and gastric subepithelial lesions (SELs) are lesions that originate from the submucosal or muscularis propria layers of the stomach wall and are often detected incidentally during endoscopic or radiologic evaluations. Studies have reported that SELs are found in approximately 0.36%–3% of upper gastrointestinal endoscopies, with the stomach as the most common site [1,2,3]. These tumors include a variety of histological entities, including gastrointestinal stromal tumors (GISTs), leiomyomas, schwannomas, neuroendocrine neoplasm (NENs), and other rare neoplasms. Although many esophageal and gastric SELs are benign and asymptomatic, some exhibit malignant potential, necessitating careful evaluation and appropriate management.
The primary surgical objective in treating patients with esophageal and gastric SELs, particularly GISTs, is to achieve complete tumor resection while minimizing the risk of tumor rupture. Special caution must be taken to prevent tumor spillage or capsular disruption, as such occurrences may lead to peritoneal contamination, increasing the risk of tumor dissemination and recurrence. Notably, lymphadenectomy is not required in the surgical management of these lesions.
Various surgical techniques are available for treating esophageal and gastric SELs, including open surgery, laparoscopic resection (LR), endoscopic resection (ER), and laparoscopic-endoscopic cooperative surgery (LECS), each with its advantages and limitations. The evolution of minimally invasive approaches has been driven by the goal of reducing postoperative morbidity and expediting recovery.
LR is a minimally invasive laparoscopic surgery that involves small incisions, reducing postoperative pain, expediting recovery, and decreasing postoperative complications compared with open surgery. However, the technique is limited in cases where tumors are in difficult-to-access locations, such as the esophagogastric junction (EGJ) or pyloric region, where an aggressive wedge resection may lead to gastric deformity and stricture.
ER has many techniques, such as endoscopic submucosal dissection (ESD), submucosal tunneling endoscopic resection (STER), endoscopic submucosal muscularis resection (ESMR), and endoscopic full-thickness resection (EFTR), that have been developed for the resection of gastric SELs. ESD enables en bloc resection but carries a high risk of perforation, particularly for deeply seated tumors [4]. STER involves creating a submucosal tunnel to access and resect the lesion, followed by mucosal closure. EFTR allows for complete resection of all layers of the gastric wall. However, it poses challenges such as pneumoperitoneum due to gastric perforation, difficulty in maneuvering the endoscope, and the risk of abdominal compartment syndrome. The over-the-scope clip (OTSC) full-thickness resection device (FTRD) is an advanced endoscopic system designed for full-thickness resection of gastrointestinal lesions. The system integrates a preloaded clip and a snare for resection, allowing for en bloc excision of lesions while simultaneously sealing the defect. This technique ensures en bloc resection with minimal risk of peritoneal contamination. Despite its advantages, the OTSC FTRD has several limitations. The device is most effective for lesions ≤2 cm in diameter [5, 6], making it less suitable for larger tumors that may require alternative resection techniques. Additionally, its application is challenging in anatomically difficult locations, such as the gastric fundus and duodenum, where maneuverability is limited. Furthermore, resections performed at the EGJ or pylorus carry a heightened risk of luminal stenosis, potentially leading to postoperative obstruction and requiring further intervention.
Due to the limitations of LR and ER, LECS has emerged as a technique that combines the advantages of endoscopic intraluminal visualization with laparoscopic external access. This approach allows for precise tumor resection with adequate margins while minimizing unnecessary gastric wall excision [7]. Additionally, gastric wall defects can be closed using laparoscopic sutures or staplers, reducing the risk of postoperative stricture, particularly in critical regions such as the EGJ and pylorus. LECS may also reduce the likelihood of gastric stasis when tumors are located along the lesser curvature. Several modifications of LECS, such as inverted LECS, laparoscopy-assisted endoscopic full-thickness resection (LAEFR), the combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique (CLEAN-NET), non-exposed endoscopic wall-inversion surgery (NEWS), and closed LECS, have been developed to further refine the technique and reduce the risk of tumor spillage. The surgical techniques have been previously described in other published studies [8].
Despite the growing adoption of these techniques, comparative studies evaluating their clinical outcomes remain limited, particularly in the context of real-world practice. Understanding the efficacy, safety, and feasibility of these approaches in a tertiary referral hospital setting is crucial for guiding surgical decision-making. The present study aims to compare the outcomes of ER, LR, and LECS in the management of esophageal or gastric SELs at King Chulalongkorn Memorial Hospital, a tertiary care university hospital in Thailand, focusing on factors such as operative success rates, complete resection rates, complication rates, and hospital length of stay.
The primary objective of the present study is to compare the clinical outcomes of ER, LR, and LECS in the management of esophageal or gastric SELs at King Chulalongkorn Memorial Hospital.
Specifically, the present study aims to evaluate and compare the operative success and complete resection rates of ER, LR, and LECS. Additionally, perioperative outcomes— including operative time, intraoperative complications—and postoperative outcomes—such as length of hospital stay and postoperative complications—will be assessed.
The present study was approved by the Institutional Review Board (IRB) of King Chulalongkorn Memorial Hospital (COA No. 1102/2024). The requirement for informed consent was waived due to the retrospective design of the study. All data were anonymized to protect patient confidentiality and ensure compliance with ethical standards in biomedical research.
The present study is a retrospective analysis of patients diagnosed with esophageal or gastric SELs who underwent surgical resection at King Chulalongkorn Memorial Hospital between January 2012 and August 2022. Patient data were retrieved from medical records, including demographic information, tumor characteristics, surgical procedures, and postoperative outcomes. Patients with a confirmed diagnosis of esophageal or gastric SEL based on preoperative imaging and/or endoscopic findings and who subsequently underwent ER, LR, or LECS for tumor removal were included in the study.
Patients were excluded if they presented with an emergency condition requiring urgent intervention (such as active bleeding, perforation, and gastric outlet obstruction), underwent multi-visceral organ resection or other surgical techniques outside the three studied approaches, or had evidence of metastatic disease. Patients with incomplete medical records, including surgical details and follow-up data, were also excluded.
Patient data were retrospectively retrieved from the electronic medical records and categorized into demographic, operative, and postoperative variables, as described below:
Demographic and clinical data include patient characteristics, tumor characteristics (tumor size, site, type, and location), and patient medical history (use of antiplatelet or anticoagulant therapy). Operative data include surgical approach (ER, LR, and LECS) and intraoperative parameters (operative time [min], estimated blood loss [mL], conversion rate [proportion of cases requiring conversion to an alternative surgical technique], and intraoperative perforation). Postoperative data include complications (delayed bleeding, leakage, surgical site infection [SSI], and other postoperative complications), histopathological outcomes (margin status [negative or positive resection margins]), and length of hospital stay (d).
The primary outcome of the study was the complete resection rate for each surgical technique (ER, LR, and LECS), defined as tumor removal with negative margins on histopathological examination.
The secondary outcomes included the surgical success rate, defined as the successful removal of the lesion using the designated technique without conversion to a different technique, and complication rates, which include intraoperative bleeding, perforation, and postoperative morbidity.
The present study was conducted as a retrospective comparative analysis to evaluate the outcomes of different surgical approaches for esophageal or gastric SELs. Categorical variables were presented as counts and percentages and analyzed using Fisher’s exact test for comparisons between groups. Continuous variables were expressed as mean ± standard deviation (SD) and compared using the independent
A total of 110 patients who underwent surgical management for esophageal or gastric SELs at King Chulalongkorn Memorial Hospital were initially included in the present study. After applying the exclusion criteria, 42 patients remained for analysis. Among the 42 patients, 11 (26.2%) underwent ER, 12 (28.6%) underwent LR, and 19 (45.2%) underwent LECS. They comprised 19 males (45.2%) and 23 females (54.8%). The mean age of the study population was 61.8 years (range: 35–85 years). The mean tumor size across all groups was 2.8 cm (range: 0.7–9 cm). The difference in tumor size among groups was not statistically significant (
Demographic data of the study population
Sex | |||
Male | 19 (45.2) | – | – |
Female | 23 (54.8) | – | – |
Age: mean age (years) | 61.8 | 35–85 | – |
Tumor size (cm) | |||
Overall | 2.8 | 0.7–9 | 0.214 |
Endoscopic | 2.7 | 0.7–4.8 | – |
Laparoscopic | 3.2 | 1.7–9 | – |
Combined | 2.8 | 1.3–5.1 | – |
Antiplatelet/anticoagulant usage | |||
Antiplatelet use | 4 (9.5) | – | – |
Anticoagulant use | 1 (2.4) | – | – |
None | 37 (88.1) | – | – |
Esophageal or gastric SELs were distributed throughout the upper gastrointestinal tract, with the majority located on the lesser curvature (n = 9) and antrum (n = 9), followed by the fundus (n = 8). Other locations included the greater curvature (n = 7), EGJ (n = 6), esophagus (n = 3), and gastric body (n = 1).
Of the 42 tumors, 9 (21.4%) exhibited an exophytic growth pattern, while 33 (78.6%) were classified as endophytic tumors.
The most common histopathological diagnosis was GIST, accounting for 21 cases (50%), followed by leiomyoma (n = 9, 21.4%) and ectopic pancreas (n = 6, 14.3%). Other less common diagnoses included schwannoma (n = 3, 7.1%), NENs (n = 1, 2.4%), accessory spleen (n = 1, 2.4%), and inflammatory fibroid polyp (n = 1, 2.4%).
A total of 42 patients underwent surgical management for esophageal and gastric SELs using three different approaches: ER, LR, and LECS as shown in
Operative techniques used in gastric SEL resection
ER | |
Total | 11 (26.2) |
ESD | 5 |
Hybrid ESD | 1 |
STER | 2 |
ESMR | 1 |
OTSC with FTRD | 1 |
EFTR | 1 |
LR | |
Total | 12 (28.6) |
Wedge resection | 8 |
Anatomical resection | 4 |
LECS | |
Total | 19 (45.2) |
LECS | 16 |
NEWS | 1 |
CLEAN–NET | 2 |
CLEAN–NET, combination of laparoscopic and endoscopic approaches to neoplasia with a non-exposure technique; EFTR, endoscopic full–thickness resection; ER, endoscopic resection; ESD, endoscopic submucosal dissection; ESMR, endoscopic submucosal muscularis resection; FTRD, full-thickness resection device; LECS, laparoscopic– endoscopic cooperative surgery; LR, laparoscopic resection; NEWS, non-exposed endoscopic wall-inversion surgery; OTSC, over-the-scope clip; SEL, subepithelial lesion; STER, submucosal tunneling endoscopic resection.
ER was predominantly used for endophytic tumors (91%), with only one case involving an exophytic tumor (9%). LR was performed on a nearly equal proportion of endophytic (58.3%) and exophytic (41.7%) tumors. LECS was primarily performed for endophytic tumors (84.2%), with a smaller proportion of exophytic tumors (15.8%).
The distribution of surgical approaches based on tumor growth patterns (endophytic vs. exophytic) is summarized in
Surgical approach based on tumor growth pattern
ER | |
Total | 11 (26.2) |
Endophytic | 10 (91.0) |
Exophytic | 1 (9.0) |
LR | |
Total | 12 (28.6) |
Endophytic | 7 (58.3) |
Exophytic | 5 (41.7) |
LECS | |
Total | 19 (45.2) |
Endophytic | 16 (84.2) |
Exophytic | 3 (15.8) |
ER, endoscopic resection; LECS, laparoscopic–endoscopic cooperative surgery; LR, laparoscopic resection.
These findings suggest that there is a surgeon preference for ER and LECS approaches for endophytic tumors, while LR is more commonly used for exophytic tumors.
Esophageal tumors were almost treated with ER, reflecting the minimally invasive approach preferred in this area. Tumors at the EGJ were more frequently treated with combined surgery. Fundus, lesser curvature, and antrum tumors were more evenly distributed across all three approaches but slightly favored laparoscopic surgery, indicating that all approaches were considered viable options in these locations.
Tumor location appears to be an important factor in determining the surgical approach selected by the surgeon (
Tumor location by surgical approach
Esophagus | 3 | – | – |
EGJ | – | – | 6 |
Fundus | 2 | 4 | 2 |
Greater curvature | 2 | – | 5 |
Lesser curvature | 1 | 4 | 4 |
Antrum | 3 | 3 | 2 |
Body | – | 1 | – |
EGJ, esophagogastric junction; ER; endoscopic resection; LECS; laparoscopic-endoscopic cooperative surgery; LR; laparoscopic resection.
The overall success rate for all surgical approaches was 95.2%, with no significant difference among groups (
The complete resection rate was significantly different among the groups (
The mean operative time varied among the three approaches, with LR achieving the shortest duration (2.8 h), followed by ER (3.6 h), while LECS required the longest operative time (5.1 h). The difference in operative time between groups was not statistically significant (
ER was associated with an intraoperative perforation rate of 45.5%; however, all cases were successfully managed with endoscopic closure techniques, with no instances of postoperative leakage. This finding highlights the inherent risk of deep-layer injury in endoscopic procedures, particularly in tumors originating from or infiltrating the muscularis propria.
Delayed bleeding was more common in the ER group (18.2%), but this difference was not statistically significant (
SSI occurred in 8.3% of the LR group and 5.3% of the LECS group.
Other complications, including pulmonary complications and intra-abdominal collections, were observed in 12.7% of the LR group, 5.3% of the LECS group, and none in the ER group (
ER resulted in the shortest hospital stay (3.9 d), which aligns with its minimally invasive nature and faster recovery time. LR had the longest hospital stay (9.3 d), likely due to postoperative recovery needs, pain management, and potential for delayed gastric motility following resection. LECS resulted in an intermediate hospital stay (6.7 d), balancing the benefits of minimally invasive techniques with the need for postoperative monitoring. However, the differences in hospital stay across groups were not statistically significant (
Clinical outcomes by surgical approach
Success rate | 10/11 (90.9%) | 11/12 (91.7%) | 19/19 (100%) | 40/42 (95.2%) | 0.438 |
Complete resection | 5/11 (45.5%) | 12/12 (100%) | 16/19 (84.2%) | 33/42 (78.6%) | 0.033 |
Operative time (h) | 3.6 | 2.8 | 5.1 | 0.880 | |
Hospital stay (d) | 3.9 | 9.3 | 6.7 | 0.877 | |
Complications | |||||
Intraoperative perforation | 5/11 (45.5%) | 0/12 (0%) | 0/19 (0%) | 5/42 (11.9%) | <0.001 |
Leakage | 0/11 (0%) | 0/12 (0%) | 0/19 (0%) | 0/42 (0%) | |
Delayed bleeding | 2/11 (18.2%) | 0/12 (0%) | 0/19 (0%) | 2/42 (4.8%) | 0.052 |
SSI | 0/11 (0%) | 1/12 (8.3%) | 1/19 (5.3%) | 2/42 (4.8%) | 0.656 |
Other complications | 0/11 (0%) | 2/12 (12.7%) | 1/19 (5.3%) | 3/42 (7.1%) | 0.289 |
Hospital stay (d) | 3.9 | 9.3 | 6.7 | 0.877 |
ER, endoscopic resection; LECS, laparoscopic-endoscopic cooperative surgery; LR, laparoscopic resection; SSI, surgical site infection.
Esophageal and gastric SELs encompass a heterogeneous group of lesions that require careful management to ensure optimal clinical outcomes. Minimally invasive techniques, including ER, LR, and LECS, have been widely adopted to achieve complete tumor removal while preserving gastric function. The present study aimed to compare these three approaches in terms of complete oncological resection, technical success, and postoperative complications among patients treated at King Chulalongkorn Memorial Hospital.
Our findings revealed significant differences in complete resection rates among the three techniques. LR demonstrated the highest success rate (100%), followed by LECS (84.2%), while ER had the lowest (45.5%) (
LECS is a hybrid surgical technique that integrates the advantages of endoscopy and laparoscopy, initially introduced by Hiki et al. [14]. Before the development of LECS, LR was the standard approach for treating SELs. However, the external appearance of gastric SELs is often unremarkable, especially in the endophytic pattern, making it challenging to accurately determine resection margins using LR alone [15,16,17]. This limitation may result in either incomplete or excessive resection, potentially increasing the risk of tumor recurrence or leading to postoperative gastric stasis and altered gastric function. The primary advantages of LECS include precise tumor resection with minimal surgical margins, preservation of gastric motility, and maintenance of postoperative quality of life. This is particularly beneficial for SELs located in the EGJ, as it can prevent the need for total or proximal gastrectomy [17]. In the present study, the LECS group comprised classic LECS in 16 out of 19 cases, NEWS in 1 case, and the CLEAN-NET in 2 cases. These newer LECS techniques have been developed to minimize the risk of tumor spillage and reduce the likelihood of peritoneal contamination and subsequent infection or tumor seeding.
Our results showed a higher delayed bleeding rate in the ER group (18.2%), compared to 0% in LR and LECS. Postoperative bleeding following ER is a recognized complication that can occur shortly after the procedure or up to several weeks postoperatively, with the highest incidence observed within the first 24 h. Clinical manifestations may include hematemesis, melena, hemodynamic instability, and a decline in hemoglobin levels. Several risk factors have been associated with postoperative bleeding, including lesion size, resection defect size, and tumor location. Additionally, patient-related factors, such as advanced age and underlying comorbidities, contribute to an increased risk. Procedural factors, including intraoperative bleeding, adequacy of hemostasis, use of anticoagulant or antiplatelet therapy, and the experience level of the endoscopist, also play a critical role in the likelihood of postoperative hemorrhage. Identifying and mitigating these risk factors is essential to improving patient outcomes and minimizing complications following ER [18, 19]. While endoscopic techniques are considered minimally invasive, they carry a high risk of intraoperative perforation. Intraoperative perforation is a recognized complication of ER with reported incidence rates ranging from 1.2% to 5.2%. Several risk factors have been identified, including lesion size, lesion characteristics, anatomical location, and procedure duration. ER performed for lesions exceeding 20 mm in diameter, deeply infiltrating lesions, or those located in the middle and upper gastrointestinal tract has been associated with a higher risk of perforation. Additionally, the presence of fibrosis at the lesion site, piecemeal resection, and procedures exceeding 2 h have been linked to an increased likelihood of perforation [9, 10, 12, 13, 20]. Careful patient selection, preoperative planning, and advanced endoscopic techniques are essential in minimizing the risk of this complication and ensuring optimal procedural outcomes.
In contrast, in the present study, LECS demonstrated the lowest overall complication rate, reinforcing its safety advantage over ER and LR, which is consistent with prior systematic review and meta-analysis studies [4]. Despite these advantages, LECS has inherent limitations, including the risk of peritoneal contamination with tumor cells or gastric contents due to intentional opening of the gastric wall, as well as the requirement for advanced endoscopic and laparoscopic expertise [21, 22].
The findings of the present study highlight the significant role of patient selection in determining the most appropriate surgical approach for the management of esophageal and gastric SELs. Key factors influencing surgical decision-making include tumor growth pattern, anatomical location, depth of tumor, and the technical expertise of the surgeon. For smaller, intraluminal tumors, ER may be a suitable approach; however, preoperative evaluation of tumor depth using EUS is essential to ensure appropriate case selection. Moreover, careful consideration must be given to the risk of perforation, particularly in tumors originating from the muscularis propria layer. Additionally, expertise in endoscopic closure techniques and proficiency in hemostatic management are critical in reducing the risk of intraoperative and postoperative complications.
LR remains a viable and effective approach, particularly for larger or deeply located tumors. However, in the present study, LR was associated with a prolonged hospital stay, consistent with findings from previous meta-analyses [4].
LECS, as an emerging hybrid technique, appears to provide an optimal balance between efficacy and safety, offering precise tumor resection while preserving gastric function and minimizing the risk of postoperative complications.
Several limitations should be acknowledged. First, the sample size was relatively small, which may limit the generalizability of the findings. Second, this retrospective study includes selection bias, as the choice of surgical technique was influenced by surgeon preference based on patient clinical factors, potentially impacting the comparability of outcomes across different approaches. Future research should focus on multi-center studies with larger sample sizes and longer follow-up durations to better understand the long-term benefits and risks associated with each technique.
In summary, the present study provides a comparative analysis of ER, LR, and LECS in the management of esophageal and gastric SELs. While all three techniques demonstrated a high technical success rate, ER was associated with the lowest rate of complete resection and the highest risk of delayed bleeding. These findings highlight the importance of individualized surgical planning, considering factors such as tumor size, location, and depth of invasion, to optimize clinical outcomes in patients with esophageal and gastric SELs.